CCM Stock Dips Amid Declining Financial Performance in the Medical Facilities Sector

Author's Avatar
Oct 17, 2024

Shares of Concord Medical Services Holdings Limited (CCM, Financial) experienced a significant drop, plummeting 8.76%. The stock price fell to $7.81 with a trading volume of 2,567 shares and a turnover rate of 0.06%. The stock's price volatility was recorded at 0.58%.

Recent financial reports reveal that Concord Medical Services Holdings Limited posted a revenue of $30.32 million but suffered a net loss of $23.87 million. This resulted in an earnings per share of -$5.46 and a gross loss of $5.76 million with a price-to-earnings ratio of -0.69. No institutional ratings or recommendations are currently available for the stock.

Within the medical facilities sector, which saw an overall decline of 0.68%, stocks like P3 Health Partners Inc., Newgenivf Group Limited, and Sonida Senior Living, Inc. registered significant increases. Meanwhile, Newgenivf Group Limited, Imac Holdings, Inc., and AMN Healthcare Services Inc. were notably active, demonstrating turnover rates of 37.33%, 14.13%, and 1.67% respectively. Stocks showing significant volatility included Newgenivf Group Limited C/Wts 03/04/2029, Newgenivf Group Limited, and P3 Health Partners Inc., with amplitude figures of 39.53%, 35.25%, and 25.87% respectively.

Concord Medical Services Holdings Limited operates radiotherapy and diagnostic imaging centers in China, with partnerships across multiple regions. The company’s network encompasses radiotherapy centers, diagnostic imaging centers, and other facilities offering services like EEG for epilepsy diagnosis, hyperthermia to enhance radiotherapy and chemotherapy effectiveness, and high-intensity focused ultrasound therapy for cancer treatment. It also provides stereotactic radiofrequency ablation for Parkinson's disease and various diagnostic services for eye conditions.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.